| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/04/2008 | WO2008104736A1 Improved medicinal compositions comprising buprenorphine and nalmefene |
| 09/04/2008 | WO2008104735A1 Improved medicinal compositions comprising buprenorphine and naltrexone |
| 09/04/2008 | WO2008104734A1 Treatment of anxiety disorders with minocycline |
| 09/04/2008 | WO2008104580A1 New use of glutaminyl cyclase inhibitors |
| 09/04/2008 | WO2008104524A1 Thiadiazole derivatives, inhibitors of stearoyl-coa desaturase |
| 09/04/2008 | WO2008104386A2 Method for the treatment of amyloidoses |
| 09/04/2008 | WO2008104385A1 Method for the treatment of amyloidoses |
| 09/04/2008 | WO2008104200A1 Use of apyrase for the treatment of a pathology resulting from endotoxin activity |
| 09/04/2008 | WO2008104199A1 Use of ecto-phosphatases for the treatment of (acute) myocardial infarction |
| 09/04/2008 | WO2008104124A1 Screening method of combination pharmaceuticals, pharmaceuticals obtained by the method and uses thereof |
| 09/04/2008 | WO2008104065A1 Neural cell preparations and methods of making and using them |
| 09/04/2008 | WO2008086678A3 The medical use of levo-phencynonate as neuroprotective agent |
| 09/04/2008 | WO2008063301A3 Pharmaceutical compositions |
| 09/04/2008 | WO2008063114A9 Amino- imidazolones and their use as medicament for treating cognitive impairment alzheimer disease, neurodegeneration and dementia |
| 09/04/2008 | WO2008048670A3 Compositions and methods for modulating tlr14 activity |
| 09/04/2008 | WO2008000513A3 Peptide compounds for the treatment of hyperexcitability disorders and diseases associated with ion channel dysfunction |
| 09/04/2008 | WO2007144195A3 Pharmaceutical composition with synergistic anticonvulsant effect |
| 09/04/2008 | WO2007139826A3 Method for elevating prolactin in mammals |
| 09/04/2008 | US20080214820 The desired characteristics of chiral compounds helps reduce the toxicity of compound; to treat mood disorders, depression; pain, neurodegenerative disorders, sexual disorders, drug abuse etc. |
| 09/04/2008 | US20080214781 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 09/04/2008 | US20080214673 e.g. Furan-3-carboxylic acid [(1R,3R)-3-(3-chloro-phenylethynyl)-3-hydroxy-cyclohexyl]-amide; metabotropic glutamate receptors modulator/antagonist;anxiolytic agent, antidepressant; amidation of amine-compounds |
| 09/04/2008 | US20080214668 Use of retinoids to treat high blood pressure and other cardiovascular disease |
| 09/04/2008 | US20080214663 Levodopa dimethyl-substituted diester prodrugs compositions, and methods of use |
| 09/04/2008 | US20080214662 Methods for the treatment of dementia based on apo e genotype |
| 09/04/2008 | US20080214651 Administering Atorvastatin; purer, more stable, more advantageous manufacturing properties than the amorphous product |
| 09/04/2008 | US20080214645 Administering 2-(1H-1-Indol-3-ylsulfanyl)benzyl]dimethyl amine; general anxiety disorder, social anxiety disorder, post traumatic stress disorder, obsessive compulsive disorder, panic disorder, panic attacks, specific phobias, social phobia and agoraphobia |
| 09/04/2008 | US20080214639 Leuprolide acetate and acetylcholinesterase inhibitors/NMDA receptor antagonists for the treatment of alzheimer's disease |
| 09/04/2008 | US20080214628 Administering a compound (2S)-(4E)-N-methyl-5-(5-isopropoxy-3-pyridyl-4-penten-2-amine; attention deficit disorder |
| 09/04/2008 | US20080214626 Methods for prevention and treatment of diseases causes by hypertension |
| 09/04/2008 | US20080214623 N-(2,2-Dimethylpropyl)-6-{3-fluoro-5-[(3-isoxazolylamino)carbonyl]-2-methylphenyl}-3-pyridinecarboxamide; inhibitors of p38 kinase |
| 09/04/2008 | US20080214620 Novel inhibitors of glutaminyl cyclase |
| 09/04/2008 | US20080214613 Substituted benzimidazole compounds with dual NOS inhibitory activity and mu opioid agonist activity |
| 09/04/2008 | US20080214609 compounds that agonize the membrane-associated estrogen receptor identified herein act as neuroprotectants to reduce neuronal cell death in response to ischemic stroke and inhibit reperfusion injury |
| 09/04/2008 | US20080214607 Heteroaromatic quinoline compounds |
| 09/04/2008 | US20080214605 to potentiate the effects of the other CNS agents; probes for the localization of cell surface receptors;3-(methylthio)-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide; depression, anxiety, schizophrenia, cognitive disorders, obesity, irritable bowel syndrome, emesis, pre-eclampsia, etc. |
| 09/04/2008 | US20080214603 5-Ht7 Receptor Antagonists |
| 09/04/2008 | US20080214602 N-Biarylamides |
| 09/04/2008 | US20080214601 2-alkylbenzoxazole carboxamides as 5ht3 modulators |
| 09/04/2008 | US20080214593 Tetracyclic amino and carboxamido compounds and methods of use thereof |
| 09/04/2008 | US20080214592 Administering an opioid antagonist or opioid receptor partial agonist and a compound that modulates monoaminergic synaptic activity; anxiety disorder, obsessive compulsive disorder |
| 09/04/2008 | US20080214591 N-Aryl Diazaspirocyclic Compounds and Methods of Preparation and Use Thereof |
| 09/04/2008 | US20080214586 2-Amino-4-Phenylquinazoline Derivatives and the Use Thereof as Hsp90 Modulators |
| 09/04/2008 | US20080214583 2-amino-4,5-dimethyl-1-(3-chlorophenyl)-1H-pyrrolo-3-carbonitrile; asthma, eczema or psoriasis |
| 09/04/2008 | US20080214578 2R)-2-[(2-amino-5-{[(1S)-1-(2-fluorophenyl)ethyl]thio}[1,3]thiazolo[4,5-d]pyrimidin-7-yl)amino]pentan-1-ol; neurodegenerative disorders, demyelinating disease, cardio- and cerebrovascular atherosclerotic disorders, peripheral artery disease, rheumatoid arthritis, pulmonary diseases su COPD, asthma |
| 09/04/2008 | US20080214577 8-(3',5'-Dichlorobiphenyl-3-yl)-8-(4-methoxyphenyl)-3-(methylsulfonyl)-2,3,4,8-tetrahydroimidazo[1,5-a]pyrimidin-6-amine 2.0 acetate; cognitive impairment, Alzheimer Disease, neurodegeneration and dementia |
| 09/04/2008 | US20080214575 Piperidine derivatives useful as ccr5 antagonists |
| 09/04/2008 | US20080214572 Selected Tetracyclic Tetrahydrofuran Derivatives Containing a Cyclic Amine Side Chain |
| 09/04/2008 | US20080214571 e.g. 1-(3-Phenylsulfonyl-phenyl)piperazine; serotonin receptor modulator; anxiolytic agent, antidepressant, cognition activator; schizophrenia, obesity, Alzheimer's disease |
| 09/04/2008 | US20080214570 Therapeutic Agents |
| 09/04/2008 | US20080214566 Bioavailability, solubility; free drug form; schizophrenia |
| 09/04/2008 | US20080214542 1-(5-methoxyisoindolin-2-yl)-6-[4-(3-trifluoromethylphenyl)piperazin-1-yl]hexan-1-one; amidation of an isoindole with a 4-phenylpyrimidinylalkanoic acid or amination of a N-haloalkylcarbonyl isoindole with a 4-phenylpyrimidine; antidepressant, neuroleptic agent; drug abuse, impotency, Parkinson's Disease |
| 09/04/2008 | US20080214540 3-[(phenyl or benzothiazol-2-yl)methyl]indole-N-acetic acids and esters; analgesics; aldose reductase inhibitors; diabetes complications including cataracts, retinopathy, nephropathy, and neuropathy; side effect reduction |
| 09/04/2008 | US20080214539 Benzisoxazole Piperidine Compounds and Methods of Use Thereof |
| 09/04/2008 | US20080214520 e.g. 7-Chloro-3-(2,2,2-trifluoroacetyl)-6-trifluoromethanesulfonyloxy-2,3,4,5-tetrahydro-1H-benzo[d]azepine; antidepressant, anxiolytic agent; obesity, obsessive/compulsive disorder |
| 09/04/2008 | US20080214511 e.g. 5-Amino-4'-chloro-13-dihydrospiro[indene-2,5'-pyrrolo[2,3-d]pyrimidin]-6'(7'H)-one; Calcitonin Gene-Related Peptide Receptor antagonist; anlgesic agent; headache, migraine or cluster headache |
| 09/04/2008 | US20080214508 O-phosphonooxymethyl propofol disodium salt; anasthetic, analgesic, anxiolytic agent, antidepressant; bioavailable and pharmacologically active when given by intravenous, than subcutaneous or rectal administration |
| 09/04/2008 | US20080214496 Iron(III) polymaltose complex and iron(III)maltodextrin complex; improvements in immune defence and/or brain performance in patients who had a normal hematological result in respect of iron status |
| 09/04/2008 | US20080214482 Retromer-based assays and methods for treating alzheimer's disease |
| 09/04/2008 | US20080214434 Administering high density lipoprotein |
| 09/04/2008 | US20080213888 Neural precursor cells, method for the production and use thereof in neural defect therapy |
| 09/04/2008 | US20080213416 obtained by extraction with a 70% methanol solvent in an ultrasound extractor; administered to the mammal in need thereof in a dosage of 0.1 mg to 500 mg of extract per kilogram |
| 09/04/2008 | US20080213406 Compositions and methods for enhancing cognitive function |
| 09/04/2008 | US20080213381 Coated tablet; an active ingredient, excipient, a swellable composition and a reactive composition; a water insoluble polymer surrounding the core, and leachable component |
| 09/04/2008 | US20080213378 Atorvastatin; lovastatin; a keto analog of mevinolin; pravastatin; simvastatin; velostatin; fluindostatin; cetyl pyridinium, polymer, biopolymer surface stabilizers; suspensions, gels, aerosols, ointments, creams, controlled release; oral, pulmonary, rectal, opthalmic; improved pharmacokinetic profiles |
| 09/04/2008 | US20080213351 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 09/04/2008 | US20080213343 Oral, Quickly Disintegrating Film, which Cannot be Spit Out, for an Antiemetic or Antimigraine Agent |
| 09/04/2008 | US20080213340 Alzheimer's prevention oral vaccines; inserting expression vector into agrobacterium and culturing |
| 09/04/2008 | US20080213315 free of non-300 kD botulinum toxin type A complexes |
| 09/04/2008 | US20080213313 Botulinum toxin treatments |
| 09/04/2008 | US20080213312 Botulinum toxin treatments |
| 09/04/2008 | US20080213304 Immunogenic composition or vaccine of enteric reovirus strains; avian reovirus in a live, attenuated or killed form; veterinary medicine; twisted neck, tremors; poultry, fowl |
| 09/04/2008 | US20080213283 Using interleukin-1 inhibitor as therapeutic agent in treatment of spinal cord injury and nervous system disorders; for example, Pralnacasan (VX-740), thalidomide, pentoxifylline, a lazaroid, cyclosporin A |
| 09/04/2008 | US20080213282 Therapeutic mixture comprising antibody fragment specifc to nerve growth factor for use in treatment of neuropathic pain |
| 09/04/2008 | US20080213276 G-protein coupled receptor specific immunoglobulin for use in treatment of neurodegenerative, spinal cord, psychological disordrers |
| 09/04/2008 | US20080213271 Using dopamine receptor specific immunoglobulin to enhance dopaminergic neurotransmission and treat or prevention nervous system and/or neuropsyciatric disorders |
| 09/04/2008 | US20080213259 Methods for Treating Autoimmune and Chronic Inflammatory Conditions Using Antagonists of CD30 or CD30L |
| 09/04/2008 | US20080213250 Use of Eph Receptor Inhibitors for the Treatment of Neurodegenerative Diseases |
| 09/04/2008 | US20080213244 Glutamate Receptor Antagonists as Neuroprotectives |
| 09/04/2008 | US20080213234 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 09/04/2008 | US20080213232 Radial Glial Cells Promote Nerve Regeneration and Functional Recovery Following Spinal Cord Injury |
| 09/04/2008 | US20080213226 Using nitrosomonas mixture in powder, cream, stick and/or salve to oxidize nitric oxide and nitric oxide precursors in order to treat and/or prevent vascular, nervous system, blood and eating disorders |
| 09/04/2008 | US20080213221 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 09/04/2008 | DE202008007923U1 Suppositorium Suppository |
| 09/04/2008 | DE102007010077A1 Use of 1,3-dioxane derivatives to enhance the activity of gamma-aminobutyric acid (GABA) on GABA-A receptors |
| 09/04/2008 | DE102007009888A1 Use of S-(+)-ketamine for treating depression, which is therapy-refractive depression, preferably depressive episode, relapsing disorder and bipolar affective disorder |
| 09/04/2008 | CA2679446A1 New use of glutaminyl cyclase inhibitors |
| 09/04/2008 | CA2679300A1 Amino acid composition |
| 09/04/2008 | CA2679263A1 Sulfonamide compound |
| 09/04/2008 | CA2679126A1 Macrocyclic compound |
| 09/04/2008 | CA2678675A1 Improved medicinal compositions comprising buprenorphine and naloxone |
| 09/04/2008 | CA2678568A1 Improved medicinal compositions comprising buprenorphine and nalmefene |
| 09/04/2008 | CA2678481A1 Improved medicinal compositions comprising buprenorphine and naltrexone |
| 09/04/2008 | CA2675953A1 Therapeutic agent for spinal cord injuries |
| 09/03/2008 | EP1964921A2 The high bone mass gene of 11q13.3 |
| 09/03/2008 | EP1964845A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/03/2008 | EP1964844A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/03/2008 | EP1964574A1 Method for treatment or prevention of disease associated with functional disorder of regulatory t cell |
| 09/03/2008 | EP1964567A1 Pharmaceutical preparation for treating migraine |
| 09/03/2008 | EP1964559A1 Compositions for the prevention and treatment of vascular dementia |
| 09/03/2008 | EP1964551A1 Compositions for the prevention and treatment of primary headache and migraine |